New York, NY (PRWEB) April 03, 2013
The Tisch MS Research Center of New York announced today that Dr. Saud A. Sadiq has accepted an invitation to participate in the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture to be held within the Vatican, April 11-13, 2013. The invitation came directly from the Vatican’s renowned Pontifical Council for Culture, NeoStem, The Stem for Life Foundation, and STOQ International, as these organizations continue to promote their charter of raising global awareness on adult stem cell usage.
“This invitation is not only a personal honor for me, but more importantly brings to the forefront the discoveries and innovative research being conducted at the Tisch MS Research Center of New York,” stated Dr. Sadiq, Director and Senior Research Scientist at the Center. He added, “The amazing collaborative effort on the part of the Pontifical Council for Culture, NeoStem, The Stem for Life Foundation, and STOQ International exemplifies the tremendous need to explore the use of regenerative medicine via stem cell therapy and end patient suffering.”
Dr. Sadiq will be presenting on the topic of cell therapies for MS within the “Hope for the Future” segment introduced by Meredith Vieira, American journalist and national TV correspondent. Dr. Sadiq will share the wealth of clinical data the Tisch MS Research Center of New York has gathered on the use of autologous adult stem cells.
ABOUT TISCH MS RESEARCH CENTER OF NEW YORK
For over twenty years, Dr. Saud A. Sadiq has believed that combining excellence in clinical care with innovative research targeted at finding the cure for multiple sclerosis would set an exemplary standard in the treatment of people with MS. Today, the Tisch MS Research Center of New York embodies this new model of healthcare, in which your doctor is also your researcher. Dr. Sadiq helps those with MS by conducting cutting-edge, patient-based research to ensure unparalleled care. The close relationship of the non-profit research center and its affiliated clinical practice (International Multiple Sclerosis Management Practice http://www.imsmp.org) enables the testing of new MS treatments and accelerates the pace at which research discoveries move from lab bench to bedside. The Tisch MS Research Center of New York aims to identify the disease trigger, optimize treatments for patients and repair the damage caused by multiple sclerosis. http://www.tischms.org.